Limits...
Contacting dropouts from type 2 diabetes care in public primary health care: description of the patient population

View Article: PubMed Central - PubMed

ABSTRACT

Objective: To characterize dropouts from type-2 diabetes (T2D) care in communal primary health care.

Design: An observational study.

Setting: In a Finnish city, patients with T2D who had not contacted the public primary health care system during the past 12 months were identified with a computer based search and contacted by a trained diabetes nurse.

Subjects: Dropouts from T2D treatment.

Main outcome measures: Demographic factors, laboratory parameters, examinations, medications, and comorbidities.

Results: Of the patients with T2D, 10% (n = 356) were dropouts and 60% of them were men. Median HbA1c was 6.5 (QR for 25% and 75%: 6.0, 7.7) %, (45 [42,61] mmol/mol). Of the dropouts, 14% had HbA1c ≥ 9.0% (75 mmol/mol), and these patients were younger than the other dropouts (mean age 54.4 [SD 10.8] years vs. 60.6 [9.4] years, p < 0.001). Median low-density lipoprotein (LDL) cholesterol level was 2.8 (QR 2.1, 3.4) mmol/l. Median systolic blood pressure (BP) was 142 (QR 130, 160) mm Hg. Median diastolic BP was 86 (78, 94) mm Hg. Of the dropouts, 83% had comorbidities and 62% were prescribed metformin as a treatment.

Conclusions: Ten percent of T2D patients were dropouts of whom those with a poor glycaemic control were younger than the other dropouts. BP and LDL cholesterol concentrations were non-optimal among the majority of the dropouts. Metformin was prescribed less frequently to the dropouts than is usual for T2D patients. The comorbidities were equally common among the dropouts as among the other T2D patients.

Key points: Which kinds of patients are dropouts from type-2 diabetes care is not known.

Key points: • One-tenth of the patients with T2D were dropouts and they generally had good glycaemic control.

Key points: • Blood pressure and LDL cholesterol concentrations were non-optimal among the majority of the dropouts.

Key points: • Fourteen percent of these dropouts had HbA1c > 9% (75 mmol/mol) and they were more often younger than the other dropouts.

Key points: • Fourteen percent of these dropouts had HbA1c > 9% (75 mmol/mol) and they were more often younger than the other dropouts.

No MeSH data available.


Distribution of dropouts in different HbA1c –groups. ***p < 0.001, χ2 test.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC5036016&req=5

Figure 0002: Distribution of dropouts in different HbA1c –groups. ***p < 0.001, χ2 test.

Mentions: Figure 2 shows the distribution of dropouts in different HbA1c groups. Of the dropouts, 14% had HbA1c ≥ 9.0% (75 mmol/mol); they were younger than the other dropouts (mean age 54.4 [10.8] years vs. 60.6 [9.4] years, p < 0.001) and they were more often prescribed insulin than the other dropouts (33% vs. 10%, p < 0.001), but no differences were observed in sex, duration of diabetes, BMI, number of comorbidities or social class.


Contacting dropouts from type 2 diabetes care in public primary health care: description of the patient population
Distribution of dropouts in different HbA1c –groups. ***p < 0.001, χ2 test.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC5036016&req=5

Figure 0002: Distribution of dropouts in different HbA1c –groups. ***p < 0.001, χ2 test.
Mentions: Figure 2 shows the distribution of dropouts in different HbA1c groups. Of the dropouts, 14% had HbA1c ≥ 9.0% (75 mmol/mol); they were younger than the other dropouts (mean age 54.4 [10.8] years vs. 60.6 [9.4] years, p < 0.001) and they were more often prescribed insulin than the other dropouts (33% vs. 10%, p < 0.001), but no differences were observed in sex, duration of diabetes, BMI, number of comorbidities or social class.

View Article: PubMed Central - PubMed

ABSTRACT

Objective: To characterize dropouts from type-2 diabetes (T2D) care in communal primary health care.

Design: An observational study.

Setting: In a Finnish city, patients with T2D who had not contacted the public primary health care system during the past 12 months were identified with a computer based search and contacted by a trained diabetes nurse.

Subjects: Dropouts from T2D treatment.

Main outcome measures: Demographic factors, laboratory parameters, examinations, medications, and comorbidities.

Results: Of the patients with T2D, 10% (n&thinsp;=&thinsp;356) were dropouts and 60% of them were men. Median HbA1c was 6.5 (QR for 25% and 75%: 6.0, 7.7) %, (45 [42,61] mmol/mol). Of the dropouts, 14% had HbA1c&thinsp;&ge;&thinsp;9.0% (75&thinsp;mmol/mol), and these patients were younger than the other dropouts (mean age 54.4 [SD 10.8] years vs. 60.6 [9.4] years, p&thinsp;&lt;&thinsp;0.001). Median low-density lipoprotein (LDL) cholesterol level was 2.8 (QR 2.1, 3.4) mmol/l. Median systolic blood pressure (BP) was 142 (QR 130, 160) mm Hg. Median diastolic BP was 86 (78, 94) mm Hg. Of the dropouts, 83% had comorbidities and 62% were prescribed metformin as a treatment.

Conclusions: Ten percent of T2D patients were dropouts of whom those with a poor glycaemic control were younger than the other dropouts. BP and LDL cholesterol concentrations were non-optimal among the majority of the dropouts. Metformin was prescribed less frequently to the dropouts than is usual for T2D patients. The comorbidities were equally common among the dropouts as among the other T2D patients.

Key points: Which kinds of patients are dropouts from type-2 diabetes care is not known.

Key points: &bull;&emsp;One-tenth of the patients with T2D were dropouts and they generally had good glycaemic control.

Key points: &bull;&emsp;Blood pressure and LDL cholesterol concentrations were non-optimal among the majority of the dropouts.

Key points: &bull;&emsp;Fourteen percent of these dropouts had HbA1c &gt; 9% (75&thinsp;mmol/mol) and they were more often younger than the other dropouts.

Key points: &bull;&emsp;Fourteen percent of these dropouts had HbA1c &gt; 9% (75&thinsp;mmol/mol) and they were more often younger than the other dropouts.

No MeSH data available.